Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   
National Research Forum on Nicotine Addiction - smoke spacer

Addicted to Nicotine
A National Research Forum


Program

[Some video is available for this meeting at the NIH Videocast site]



Monday, July 27
Introduction

Welcome
Alan I. Leshner, Ph.D.
National Institute on Drug Abuse, NIH
Nancy J. Kaufman, R.N.
The Robert Wood Johnson Foundation

Co-Chair Remarks
Timothy P. Condon, Ph.D.
Jaylan S. Turkkan, Ph.D.

National Institute on Drug Abuse, NIH
Section I: History and Pharmacology
Introduction
Jack E. Henningfield, Ph.D.
Johns Hopkins School of Medicine & Pinney Associates
Slides
Nicotine Delivery Systems
John Slade, M.D.
Robert Wood Johnson Medical School
University of Medicine and Dentistry of New Jersey
Slides
Pharmacology of Nicotine
Jack E. Henningfield, Ph.D.
Johns Hopkins School of Medicine & Pinney Associates
Slides
Questions and Answers
Section II: Nicotine-Individual Risk Factors for Initiation
Introduction
Richard R. Clayton, Ph.D.
Center for Prevention Research
University of Kentucky
Ethnicity, Gender and Risk Factors for Smoking Initiation
Robin Mermelstein, Ph.D.
Health Research and Policy Center
University of Illinois at Chicago
Slides
Child and Adolescent Psychopathology as Risk Factors for Tobacco Use
Robert J. McMahon, Ph.D.
Child Clinical Psychology Program
University of Washington
Slides
The Genetic Epidemiology of Smoking
Kenneth S. Kendler, M.D.
Medical College of Virginia
Virginia Commonwealth University
Slides
Nicotine Metabolism Variability and Nicotine Addiction
Karen Ahijevych, Ph.D.
College of Nursing
Ohio State University
Slides
A Common Genetic Defect in Nicotine Metabolism Decreases Smoking
Rachel Tyndale, Ph.D.
Department of Pharmacology
University of Toronto
Slides
Discussion
Moon S. Chen, Jr., Ph.D., M.P.H.
School of Public Health
Ohio State University
Discussion
Gary E. Swan, Ph.D.
Center for Health Sciences
SRI International
Slides
Questions and Answers
Keynote Address

Introduction of Keynote Address
Alan I. Leshner, Ph.D.
National Institute on Drug Abuse, NIH
Harold E. Varmus, M.D.
Director, National Institutes of Health

Keynote Address
Vice President Al Gore

Section III: Nicotine-Environmental Risk Factors for Initiation
Introduction
Nancy J. Kaufman, R.N., Chair
Robert Wood Johnson Foundation
Economics
Frank J. Chaloupka, Ph.D.
Department of Economics
University of Illinois at Chicago
Slides
Advertising and Promotion
John P. Pierce, Ph.D.
Cancer Prevention and Control Program
University of California at San Diego
Slides
Access to Tobacco
Nancy A. Rigotti, M.D.
Massachusetts General Hospital
Harvard Medical School
Slides
Effective Prevention Programs for Tobacco Use
Mary Ann Pentz, Ph.D.
Norris Cancer Center
University of Southern California
Discussion
Warren Bickel, Ph.D.
Human Behavioral Pharmacology Lab
University of Vermont
Slides
Discussion
Brian A. Flay, Ph.D.
School of Public Health
University of Illinois at Chicago
Slides
Questions and Answers
Closing Remarks
Alan I. Leshner, Ph.D.
National Institute on Drug Abuse, NIH

Tuesday, July 28
Opening Remarks
Alan I. Leshner, Ph.D.
National Institute on Drug Abuse, NIH
Jaylan S. Turkkan, Ph.D.
National Institute on Drug Abuse, NIH
Section IV: Biology of Nicotine Addiction
Introduction
Neil E. Grunberg, Ph.D.
Department of Medical and Clinical Psychology
Uniformed Services University of the Health Sciences
Neuropharmacology and Biology of Neuronal Nicotinic Receptors
Kenneth S. Kellar, Ph.D.
Department of Pharmacology
Georgetown University School of Medicine
Slides
Molecular Biology and Knockouts of Nicotinic Receptors
Marina Picciotto, Ph.D.
Department of Psychiatry
Yale University School of Medicine
Slides
Brain Chemistry and Imaging
Nora D. Volkow, M.D.
Medical Department
Brookhaven National Laboratory
Slides
Nicotine Reinforcement in Animals and Humans
Kenneth A. Perkins, Ph.D.
Western Psychiatric Institute and Clinic
University of Pittsburgh Medical Center
Slides
Discussion
William A. Corrigall, Ph.D.
Biobehavioural Research Department
Addiction Research Foundation
Slides
Questions and Answers
Section V: Psychobiology of Nicotine Addiction
Introduction
Neil E. Grunberg, Ph.D.
Department of Medical and Clinical Psychology
Uniformed Services University of the Health Sciences
Behavior/Cognitive Effects of Smoking
Stephen Heishman, Ph.D.
Intramural Research Program
National Institute on Drug Abuse, NIH
Slides
Comorbidity and Smoking
John Hughes, M.D.
Department of Psychiatry, Psychology & Family Practice
University of Vermont
Slides
Individual Differences in Smoking and Nicotine Addiction
Saul Shiffman, Ph.D.
Department of Psychology
University of Pittsburgh
Slides
Discussion
M. Marlyne Kilbey, Ph.D.
Department of Psychology
Wayne State University
Slides
Discussion
Neal L. Benowitz, M.D.
Division of Clinical Pharmacology and Experimental Therapeutics
University of California at San Francisco
Slides
Questions and Answers
Section VI: Treatment of Nicotine Dependence
Introduction
John Hughes, M.D.
Department of Psychiatry, Psychology & Family Practice
University of Vermont
Psychological Interventions
Sharon M. Hall, Ph.D.
Department of Psychiatry
University of California at San Francisco
Slides
New Medications for Nicotine Dependence Treatment
Richard D. Hurt, M.D.
Nicotine Dependence Center
Mayo Clinic
Slides
Combined Treatments
Maxine L. Stitzer, Ph.D.
Bayview Medical Center
Johns Hopkins University School of Medicine
Slides
Primary Care Based Interventions
Judith K. Ockene, Ph.D., M.Ed.
Division of Preventive and Behavioral Medicine
University of Massachusetts Medical Center
Slides
Treatment of Special Populations
Dorothy Hatsukami, Ph.D.
Department of Psychiatry
University of Minnesota
Slides
Interventions for Treatment Resistant Smokers
Karl Olav Fagerstrom, Ph.D.
Fagerstrom Consulting
Slides
Discussion
Paul M. Cinciripini, Ph.D.
M.D. Anderson Cancer Center
University of Texas
Slides
Discussion
Jasjit S. Ahluwalia, M.D., M.P.H., M.S.
Department of Preventive Medicine
University of Kansas Medical Center
Questions and Answers
Conference Overview
Conclusion: Nicotine Addiction
David B. Abrams, Ph.D.
Miriam Hospital
Brown University School of Medicine
Slides
Closing Remarks
Alan I. Leshner, Ph.D.
National Institute on Drug Abuse, NIH


[Nicotine Conference Program Index]

Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal